M&A
Sun Pharma acquires 100% stake in Canada’s pain-management focused Antibe Therapeutics
Mumbai-based Sun Pharmaceutical Industries Ltd, via its subsidiary Taro Pharmaceuticals Inc., has acquired 100% stake in Ontario, (Canada)-based Antibe Therapeutics Inc., via a “Reverse Vesting Order”.Founded in 2009, Antibe is a clinical-stage biotechnology company that develops novel drugs primarily focusing on reducing pain and inflammation. It is currently under liquidation proceedings and is being managed by a court-appointed receiver.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
